Micron’s Record Results and $250 Billion Fab Plan Collide With a $8.6 Billion Rival IPO: The Stock Slips 13%

Micron Technology is caught in a strange disconnect. The company just posted record quarterly revenue of $41.46 billion, a 346% year-over-year surge, and guided for a $50 billion fourth quarter with gross margins around 86%. Its entire high-bandwidth memory (HBM) output for 2026 is already spoken for under long-term customer agreements backed by $22 billion in prepayments. Yet the stock ended last week at €746.30, down 13% over the preceding five days and 32% below the June peak of €1,103.80.

The immediate trigger for the sell-off came from China. ChangXin Memory Technologies (CXMT), the country’s No. 1 DRAM maker, filed for an initial public offering of up to $8.55 billion on Shanghai’s STAR Market. The listing, set for July 27, would be the largest in Asia this year. CXMT intends to use the proceeds to expand production lines, and the company has already grown its global DRAM market share from roughly 3% to 8% over the past 12 months. Its first-quarter revenue jumped an eye-popping 700%, and Morningstar now values the entire business at about $80 billion.

For Micron investors, the arrival of a better-capitalized competitor is an uncomfortable development at a moment when the stock’s valuation leaves little room for error. The company is in the midst of a $250 billion U.S. investment blitz, aiming to produce 40% of its DRAM domestically. A megafab in New York is slated to start output in 2029, while a Hiroshima plant will begin churning out HBM chips by mid-2028. That kind of spending requires sustaining the current pricing environment, and additional supply from CXMT – even if technologically constrained by U.S. export controls that block access to EUV lithography – threatens to temper the pricing power that has driven Micron’s stunning turnaround.

Wall Street analysts remain broadly supportive, even with the recent weakness. Mizuho named Micron its top memory pick and lifted its target from $800 to $1,150, citing an extra 9% to 13% DRAM demand boost from "agentic AI" and an HBM market that is expected to grow 90% by 2028. TD Cowen’s Krish Sankar reiterated an outperform rating with a $1,600 target, pointing to tight supply lasting well beyond 2027. Other bullish calls include Citi at $1,400, BofA’s Vivek Arya at $1,550, and Bernstein at $1,300. The consensus among 29 buy and one hold rating sits near $1,569, implying roughly 74% upside from current levels – though one source calculates a lower average of about €1,299, underscoring the range of opinion.

Should investors sell immediately? Or is it worth buying Micron?

Institutional investors have been adding to their positions during the dip. CalPERS boosted its stake by 46.2% in the first quarter to 3.19 million shares valued at $1.08 billion. Norges Bank, AQR, and Vanguard also increased their holdings. Insider sales that attracted attention – including the CEO’s roughly $46 million worth of stock sold near the high – were executed under a pre-arranged Rule 10b5-1 trading plan set up in late January, not a reaction to current events, the company said.

Another overhang is a class-action lawsuit alleging DRAM price-fixing among Micron and other manufacturers. The complaint injects legal uncertainty into an already nervous valuation narrative. On the technical side, the relative strength index has cooled to 40.9, indicating the stock is no longer overheated but has not yet reached oversold territory. The share price sits nearly 10% below its 50-day moving average of €826.82, suggesting the market is catching its breath rather than panicking.

What makes the current moment particularly tricky is the clash between cyclical memory-market history and the super-cycle thesis fueled by AI. KeyBanc analyst John Vinh argues that DRAM and NAND prices will see double-digit increases through at least 2027, backed by structural demand. Skeptics counter that a boom-and-bust pattern has always defined the memory industry and that a stock priced for perfection leaves no buffer for any disappointment – especially from a well-funded Chinese rival that could flood the market.

Micron at a turning point? This analysis reveals what investors need to know now.

Micron’s next quarterly report in September will provide the first real test of whether the CXMT IPO and other headwinds are changing the demand calculus. Until then, the narrative remains split: record earnings, a fully booked HBM pipeline, and massive U.S. factory investments on one side; a freshly capitalized competitor, a lingering lawsuit, and a stock that has given back nearly a third of its peak value on the other. Shareholders are betting that the former outweighs the latter.

Ad

Micron Stock: New Analysis - 19 July

Fresh Micron information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Micron analysis...

en | US5951121038 | MICRON’S | boerse | 69799148 |